EcoDrugPlus

Coagulation Factor Vii

Ensembl ID : ENSSVLG00005001724
Gene Symbol: F7
1 Cross references
274 Possible Orthologues:

Coagulation Factor X

Ensembl ID : ENSSVLG00005001796
Gene Symbol: F10
1 Cross references
237 Possible Orthologues:

Coagulation Factor Xi

Ensembl ID : ENSSVLG00005011037
Gene Symbol: F11
1 Cross references
216 Possible Orthologues:

Coagulation Factor Xii

Ensembl ID : ENSSVLG00005007006
Gene Symbol: F12
1 Cross references
185 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSSVLG00005007703
Gene Symbol: CCDC6
1 Cross references
219 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSSVLG00005007891
Gene Symbol: CSF1R
1 Cross references
206 Possible Orthologues:

Complement C1s

Ensembl ID : ENSSVLG00005000584
Gene Symbol: C1S
1 Cross references
199 Possible Orthologues:

Complement C5

Ensembl ID : ENSSVLG00005015629
Gene Symbol: C5
1 Cross references
199 Possible Orthologues:

Complement Factor D

Ensembl ID : ENSSVLG00005024797
Gene Symbol: CFD
1 Cross references
133 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSSVLG00005004317
Gene Symbol: CRHR1
1 Cross references
240 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSSVLG00005023090
Gene Symbol: CCND1
1 Cross references
277 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSSVLG00005002635
Gene Symbol: CDK2
1 Cross references
202 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).